Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Notification of Proposed Production Activity; Pfizer, Inc. (Nirmatrelvir Active Pharmaceutical Ingredient (API) for COVID-19 Treatment); Kalamazoo, Michigan, 11410 [2022-04225]

Download as PDF 11410 Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices Legal Authority: Census Authority: Title 13, United States Code (U.S.C.), Section 8(b) (13 U.S.C. 8(b)). HRSA MCHB Authority: Section 501(a)(2) of the Social Security Act (42 U.S.C. 701). United States Department of Agriculture Authority: Agriculture Improvement Act of 2018, Public Law 115–334. United States Department of Health and Human Services’ Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities Authority: Public Health Service Act, Section 301, 42 U.S.C. 241. United States Department of Health and Human Services’ Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion Authority: Sections 301(a), 307, and 399G of the Public Health Service [42 U.S.C. 241(a), 242l, and 280e–11], as amended. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view the Department of Commerce collections currently under review by OMB. Written comments and recommendations for the proposed information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/ public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the collection or the OMB Control Number 0607–0990. Sheleen Dumas, Department PRA Clearance Officer, Office of the Chief Information Officer, Commerce Department. [FR Doc. 2022–04224 Filed 2–28–22; 8:45 am] BILLING CODE 3510–07–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board jspears on DSK121TN23PROD with NOTICES1 [B–6–2022] Foreign-Trade Zone (FTZ) 43—Battle Creek, Michigan; Notification of Proposed Production Activity; Pfizer, Inc. (Nirmatrelvir Active Pharmaceutical Ingredient (API) for COVID–19 Treatment); Kalamazoo, Michigan activity to the FTZ Board for its facility Kalamazoo, Michigan. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on February 22, 2022. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status materials/ components and specific finished product described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished product and materials/components would be added to the production authority that the Board previously approved for the operation, as reflected on the Board’s website. The proposed finished product is Nirmatrelvir API (duty rate, 6.5%). The proposed foreign-status materials and components include Registered Starter Chemical PF-04349713-01, Registered Starter Chemical PF07321787, Registered Starter Chemical PF-07328614-01, 2-Hydroxypyridine-Noxide (HOPO), and Dimethylaminopropylethyl carbodiimide hydrochloride (EDC HCI) (duty rates are 3.7% or 6.5%). The request indicates that certain materials/ components are subject to duties under Section 301 of the Trade Act of 1974 (Section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is April 11, 2022. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Diane Finver at Diane.Finver@trade.gov. Dated: February 23, 2022. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2022–04225 Filed 2–28–22; 8:45 am] BILLING CODE 3510–DS–P Pfizer, Inc. (Pfizer) submitted a notification of proposed production VerDate Sep<11>2014 19:01 Feb 28, 2022 Jkt 256001 PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 DEPARTMENT OF COMMERCE International Trade Administration [A–580–836] Certain Cut-to-Length Carbon-Quality Steel Plate Products From the Republic of Korea: Preliminary Results of Antidumping Duty Administrative Review; 2020–2021 Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The Department of Commerce (Commerce) preliminarily finds that producers/exporters subject to this administrative review made sales of subject merchandise at less than normal value during the period of review (POR), February 1, 2020, through January 31, 2021. We invite interested parties to comment on these preliminary results of review. DATES: Applicable March 1, 2022. FOR FURTHER INFORMATION CONTACT: Andre Gziryan, AD/CVD Operations, Office I, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–2201. SUPPLEMENTARY INFORMATION: AGENCY: Background On February 10, 2000, Commerce published in the Federal Register an antidumping duty order on certain cutto-length carbon-quality steel plate products (CTL plate) from the Republic of Korea (Korea).1 On February 2, 2021, we published in the Federal Register a notice of opportunity to request an administrative review of the Order.2 On April 1, 2021, based on timely requests for an administrative review Commerce initiated the administrative review of four companies.3 On October 14, 2021, Commerce extended the time limit for issuing the preliminary results of this review by 117 days, to no later than February 25, 2022.4 For a complete description of the 1 See Notice of Amendment of Final Determinations of Sales at Less Than Fair Value and Antidumping Duty Orders: Certain Cut-ToLength Carbon-Quality Steel Plate Products from France, India, Indonesia, Italy, Japan and the Republic of Korea, 65 FR 6585 (February 10, 2000) (Order). 2 See Antidumping or Countervailing Duty Order, Finding, or Suspended Investigation; Opportunity to Request Administrative Review, 86 FR 7855 (February 2, 2021). 3 See Initiation of Antidumping and Countervailing Duty Administrative Reviews, 86 FR 17124 (April 1, 2021) (Initiation Notice). 4 See Memorandum, ‘‘Certain Cut-to-Length Carbon-Quality Steel Plate Products from the Republic of Korea: Extension of Deadline for E:\FR\FM\01MRN1.SGM 01MRN1

Agencies

[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Page 11410]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04225]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-6-2022]


Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan; Notification 
of Proposed Production Activity; Pfizer, Inc. (Nirmatrelvir Active 
Pharmaceutical Ingredient (API) for COVID-19 Treatment); Kalamazoo, 
Michigan

    Pfizer, Inc. (Pfizer) submitted a notification of proposed 
production activity to the FTZ Board for its facility Kalamazoo, 
Michigan. The notification conforming to the requirements of the 
Board's regulations (15 CFR 400.22) was received on February 22, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status materials/components and 
specific finished product described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz. The proposed finished 
product and materials/components would be added to the production 
authority that the Board previously approved for the operation, as 
reflected on the Board's website.
    The proposed finished product is Nirmatrelvir API (duty rate, 
6.5%).
    The proposed foreign-status materials and components include 
Registered Starter Chemical PF-04349713-01, Registered Starter Chemical 
PF-07321787, Registered Starter Chemical PF-07328614-01, 2-
Hydroxypyridine-N-oxide (HOPO), and Dimethylaminopropylethyl 
carbodiimide hydrochloride (EDC HCI) (duty rates are 3.7% or 6.5%). The 
request indicates that certain materials/components are subject to 
duties under Section 301 of the Trade Act of 1974 (Section 301), 
depending on the country of origin. The applicable Section 301 
decisions require subject merchandise to be admitted to FTZs in 
privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is April 11, 2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: February 23, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-04225 Filed 2-28-22; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.